Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Helping Youth Avoid Risky Behavior: Family-Based Program
Children"s behavior is determined, in part, by their genes and by the settings in which they develop. A new longitudinal study describes how a family-based prevention program helped rural African American teens avoid engaging in risky behaviors, even if some of them may have had a genetic risk to do so.
generic viagra online
Wal-Mart Backs Employer Mandate On Insurance
"In a major break with most other large companies, Wal-Mart Stores Inc. Tuesday told the White House that it supports requiring employers to provide health insurance to workers, a centerpiece of President Barack Obama"s effort to provide near-universal coverage to Americans," The Wall Street Journal reports. "Wal-Mart -- which provides insurance to employees and wants to level the playing field with companies that don"t -- on Tuesday delivered a letter to President Obama taking a different stance." The letter was signed by Wal-Mart Chief Executive Mike Duke, as well as Andrew Stern, president of the Service Employees International Union, and John Podesta, "who led President Obama"s transition team and is chief executive of the Center for American Progress, a liberal-leaning think tank." Wal-Mart"s new stance is "a shift from its previous stance on health-care overhaul and follows years of tussles with organized labor." The Journal adds a caveat: Wal-Mart "isn"t changing its policies. The company says it supports the employer mandate because all businesses should share the burden of fixing the health-care system. ... Wal-Mart"s support for a broad mandate also appears to be aimed at beating back an alternative that may be less favorable to the company. The Senate Finance Committee is considering a measure expected to result in a more burdensome health-insurance requirement for companies that have lower-wage workers" (Adamy and Zimmerman, 7/10).
News of the day
CMS Proposes Payment, Policy Changes For Physicians Services To Medicare Beneficiaries In 2010
The Centers for Medicare & Medicaid Services (CMS) announced today proposed changes to policies and payment rates for services to be furnished during calendar year (CY 2010) by over 1 million physicians and nonphysician practitioners who are paid under the Medicare Physician Fee Schedule (MPFS). The MPFS sets payment rates for more than 7,000 types of services in physician offices, hospitals, and other settings.
Sexual Health

Stem Cell Scientists First To Be Awarded Victoria-California Collaborative Grants To Drive Stem Cell Research Forwards

committee member (1993-2000) and Chairman of the UK Association of Pharmaceutical Scientists (1999-2000), and as an elected member of the committee of the Academy of Pharmaceutical Scientists of Great Britain (2000-2001). Professor Pouton was elected a Fellow of the American Association of Pharmaceutical Scientists in 2003. Since moving to Monash University, Professor Pouton has established a research group focused on pharmaceutical applications of stem cell biology in collaboration with his MIPS colleague, Dr John Haynes. Professor Pouton has supervised 38 completed PhD students and is the author of 70 peer-reviewed publications. He has received over $7 million of independent research funds, including a current $1.8 million grant from Pfizer Inc. to investigate low molecular weight inducers of differentiation in mouse embryonic stem cells. BACKGROUND: About the Australian Stem Cell Centre The Australian Stem Cell Centre is Australia"s Biotechnology Centre of Excellence. The ASCC was selected in 2002, in a competitive bid process, as Australia"s Biotechnology Centre of Excellence (BCE), to capitalise on Australia"s significant strengths in the general field of stem cell research. The Centre provides a unique opportunity for stem cell researchers to deliver outcomes that will benefit the wider Australian biotechnology industry and ultimately contribute innovative solutions to human health challenges. The Centre was established with the financial and in-kind support of institutions ("Stakeholders"). The current voting Members, who retain ultimate oversight of the Centre, are: Monash University, University of Queensland, Florey Neuroscience Institutes and University of Adelaide. The additional Stakeholder institutes are: University of Melbourne, Baker IDI, Murdoch Children"s Research Institute, Victor Chang Cardiac Research Institute and Mater Medical Research Institute. The ASCC is governed by a Board of Directors with independent scientific oversight and support from an eminent Scientific Advisory Board. Total funding of $100 million has been awarded to the ASCC by the Australian Government and is administered by the Australian Research Council and the Department of Innovation, Industry, Science and Research. The funding is provided in instalments from 2002 to 2011. To complement Australian Government funding, the State Government of Victoria"s Science Technology and Innovation program awarded the Australian Stem Cell Centre a further $11 million to support some key infrastructure in Victoria. Together the ASCC and partnering organisations support a critical mass of Australian stem cell research that is internationally competitive. The ASCC currently funds research at leading institutes and universities in Victoria, Queensland and New South Wales with the major clusters of activity centred in Victoria and Queensland. By providing stem cell specific funding, the Centre in its first seven years of operation has supported in excess of 200 researchers, more than 70 students in over 30 research projects across Australia. About Monash University Monash University is one of Australia"s finest universities, and is recognised as a global centre of biomedical and health research. As a member of the "Group of Eight" universities that between them undertake over 70 per cent of the research conducted in Australia"s 39 universities, Monash"s capabilities and achievements have resulted in the University gaining a formidable reputation - a remarkable achievement for an institution with a history extending for only 51 years. Over 700 researchers operate within the Faculty of Medicine, Nursing and Health Sciences, not including the significant research contributions made by the Monash Institute for Medical Research, the Australian Regenerative Medicine Institute and a proliferation of research being undertaken in conjunction with our clinical schools and other partner organisations in Australia and worldwide. A clear mission to improve public health and the human condition on the widest scale permeates both the Faculty"s and the University"s vision and research objectives. Monash is also respected for its excellence in healthcare education, consistently ranked in the top 50 universities in the world, and in the top four universities in Australia, by the Times Higher Education Supplement. Monash consistently receives the highest amount of performance-based funding from the Australian Government of any university in Australia, in recognition of its teaching and learning excellence in health disciplines. From the time of its formation, Monash University has maintained a strong international focus, and can claim to be Australia"s most international university with its own campuses in Malaysia and South Africa, and a centre at Prato in Italy. About 30 per cent of the University"s students come from 130 different countries. Together with research collaborations with leading universities all over the world, this results in an international approach that helps to build cultural understanding and mutual respect - essential for peace and security through the challenging times of the 21st century. About Florey Neuroscience Institutes Florey Neuroscience Institutes (FNI) is the largest brain research group in the Southern Hemisphere and the sixth largest neuroscience facility in the world. FNI is made up of the Howard Florey Institute, the Brain Research Institute and the National Stroke Research Institute. With more than 500 research and support staff on two campuses, FNI scientists are searching for cures to the complex, debilitating and sometimes life threatening brain disorders that affect three million Australians. Through our clinical and basic research facilities in Parkville and Heidelberg, Victoria, we are investigating Parkinson"s, Huntington"s and Motor Neuron diseases. We are world leaders in Stroke and Epilepsy and brain imaging research and have exceptional teams working on Multiple Sclerosis, addiction and traumatic brain and spinal cord injury among others. Florey Neuroscience Institutes

Pages: 1 2 [3] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009